Frontiers Association of Lipoprotein(a)-Associated Mortality and

Clinical Feature: The ABCs of Lipoprotein(a)

IJERPH, Free Full-Text

Frontiers Lipoprotein(a) Induces Vesicular Cardiovascular Calcification Revealed With Single-Extracellular Vesicle Analysis

Lipoprotein (a) level as a risk factor for stroke and its subtype: A systematic review and meta-analysis

Frontiers Association Between Lipoprotein(a) and Peri-procedural Myocardial Infarction in Patients With Diabetes Mellitus Who Underwent Percutaneous Coronary Intervention

Lipoprotein(a) and Body Mass Compound the Risk of Calcific Aortic Valve Disease

The Role of Lipids and Lipoproteins in Atherosclerosis - Endotext - NCBI Bookshelf

Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study - The Lancet Diabetes & Endocrinology

Lipoprotein(a) predicts recurrent cardiovascular events in patients with prior cardiovascular events post-PCI: five-year findings from a large single center cohort study, Thrombosis Journal

Frontiers Association Between Lipoprotein(a) and Calcific Aortic Valve Disease: A Systematic Review and Meta-Analysis

Frontiers Lipoprotein(a) and Pulmonary Embolism Severity-A Retrospective Data Analysis

A Test in Context: Lipoprotein(a): Diagnosis, Prognosis, Controversies, and Emerging Therapies - ScienceDirect

Lipoprotein(a) and Risk of Ischemic Stroke in the REGARDS Study

Frontiers Lipoprotein(a) and Cardiovascular Outcomes in Patients With Coronary Artery Disease and Different Metabolic Phenotypes

Lp(a) (Lipoprotein[a]) Concentrations and Incident Atherosclerotic Cardiovascular Disease